H.C. Wainwright analyst Swayampakula Ramakanth lowered the firm’s price target on Vericel to $35 from $53 and keeps a Buy rating on the shares post the Q3 results. The analyst cites softer near-term MACI growth for the target drop.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on VCEL: